Back to Search

ANNIE MAI, PHARMD

PHARMD

Pharmacist

NPI: 1720704489Individual

Specialties, Licenses & Credentials

PharmacistPrimary

Pharmacist

Code: 183500000X

87131(CA)

Research & Publications (20)

Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors.
PMID 19663498·J Med Chem·2009
7-preclinical
Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
PMID 19144517·Bioorg Med Chem Lett·2009
8-other
Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
PMID 18790076·Int J Biochem Cell Biol·2009
6-review
Meningioma with pneumosinus dilatans.
PMID 12796553·Neurology·2003
8-other
Use of atomic force microscopy for morphological and morphometric analyses of acrosome intact and acrosome-reacted human sperm.
PMID 12412050·Mol Reprod Dev·2002
8-other
Fine-needle aspiration biopsy of an intra-abdominal inflammatory mass secondary to a penetrating duodenal ulcer mimicking neoplasm.
PMID 11747219·Diagn Cytopathol·2001
5-case
Non-cancer uses of histone deacetylase inhibitors: effects on infectious diseases and beta-hemoglobinopathies.
PMID 19355991·Curr Top Med Chem·2009
6-review
Chiral HPLC separation and absolute configuration of novel S-DABO derivatives.
PMID 18780368·Chirality·2009
8-other
Histone acetyltransferase inhibitors and preclinical studies.
PMID 19473103·Expert Opin Ther Pat·2009
6-review
The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome.
PMID 19352495·PLoS One·2009
8-other
Pyrrole-based hydroxamates and 2-aminoanilides: histone deacetylase inhibition and cellular activities.
PMID 19504533·ChemMedChem·2009
8-other
PKCepsilon regulation of an alpha5 integrin-ZO-1 complex controls lamellae formation in migrating cancer cells.
PMID 19567915·Sci Signal·2009
8-other
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
PMID 19060927·Oncogene·2009
7-preclinical
New pyrrole-based histone deacetylase inhibitors: binding mode, enzyme- and cell-based investigations.
PMID 18834955·Int J Biochem Cell Biol·2009
8-other
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes.
PMID 19498465·EMBO Rep·2009
7-preclinical
"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence.
PMID 19486542·Retrovirology·2009
8-other
Specific activity of class II histone deacetylases in human breast cancer cells.
PMID 19074835·Mol Cancer Res·2008
8-other
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.
PMID 19047631·Proc Natl Acad Sci U S A·2008
7-preclinical
HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2.
PMID 18691615·Biochim Biophys Acta·2008
8-other
5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a series of anti-HIV-1 agents of the dihydro-alkoxy-benzyl-oxopyrimidine family with peculiar structure-activity relationship profile.
PMID 18630898·J Med Chem·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
9300 CAMPUS POINT DR
LA JOLLA, CA 92037

Location

Practice Location

9300 CAMPUS POINT DR, LA JOLLA, CA
(858) 657-7000

Quick Facts

NPI
1720704489
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile